Theoretical study on mutation-induced activation of the luteinizing hormone receptor

Journal of Molecular Biology

Volumn 296, Issue 5, 2000, Pages 1333-1351

  Fanelli, Francesca ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Constitutive activity; G proteins; Luteinizing hormone receptor; Molecular dynamics; Receptor activation

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LUTEINIZING HORMONE RECEPTOR;

ARTICLE; BINDING SITE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DYNAMICS; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STRUCTURE ANALYSIS;

EID: 0034628894     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3516     Document Type: Article

References (85)

1. Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs
2. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: A site-directed spin-labeling study
3. Structural changes and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: A site-directed spin-labeling study
4. The probable arrangement of the helices in G protein-coupled receptors
5. An alpha-carbon atom template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors
6. Spectroscopic evidence for interaction between transmembrane helices 3 and 5 in rhodopsin
7. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling
8. How receptors talk to trimeric G proteins
9. Charmm: A program for macromolecular energy, minimization and dynamics calculations
10. The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling
11. Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor
12. Amino acids of the α1B-adrenergic receptor involved in agonist binding - Differences in docking catecholamines to receptor subtypes
13. Regions of the α1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function
14. Structure and function in rhodopsin: Replacement by alanine of cysteine residues 110 and 187, components of a conserved disulphide bond in rhodopsin, affects the light-activated metarhodopsin II state
15. Comparative molecular dynamics study of the seven-helix bundle arrangement of G-protein coupled receptors
16. Ab initio modeling and molecular dynamics simulation of the α1b-adrenergic receptor activation
17. Activation mechanism of human oxytocin receptor: A combined study of experimental and computer-simulated mutagenesis
18. Theoretical study on receptor/G protein recognition: New insights into the mechanism of the α1b-adrenergic receptor activation
19. Theoretical study on the electrostatically driven step of receptor-G protein recognition
20. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: A site-directed spin-labeling study
21. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin
22. The functional microdomain in transmembrane helices 2 and 7 regulates expression, activation, and coupling pathways of the gonadotropin-releasing hormone receptor
23. Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin
24. Structure of the C-terminal fragment 300-320 of the rat angiotensin II AT1A receptor and its relevance with respect to G-protein coupling
25. Structure of two fragments of the third cytoplasmic loop of the rat angiotensin II AT1A receptor
26. Residues in the 7th membrane spanning segment of the dopamine D2 receptor accessible in the binding-site crevice
27. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility
28. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor
29. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty
30. Roles of transmembrane prolines and proline-induced kinks of lutropin/choriogonadotropin receptor
31. Hamster α(1B)-adrenergic receptor directly activates G(s) in the transfected chinese hamster ovary cells
32. A cysteine residue in the 3rd membrane-spanning segment of the human D2-dopamine receptor is exposed to the binding-site crevice
33. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method
34. Residues in the fifth membrane-spanning segment of the dopamine d2 receptor exposed in the binding-site crevice
35. Constitutive activation of the β2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment
36. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice
37. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: Contribution of the second membrane-spanning segment
38. A model recognition approach to the prediction of all helical membrane protein structure and topology
39. NMR and circular dichroism studies of synthetic peptides derived from the third intracellular loop of the β-adrenoreceptor
40. 1H NMR spectroscopy
41. Assembly of functional rhodopsin requires a disulphide bond between cysteine residues 110 and 187
42. Structure and function in rhodopsin: Rhodopsin mutants with a neutral amino acid at E134 have a partially activated conformation in the dark state
43. Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site
44. Single cysteine substitution mutants at amino acid positions 55-75, the sequence connecting the cytoplasmic ends of helices I and II in rhodopsin: Reactivity of the sulfhydryl groups and their derivatives identifies a tertiary structure that changes upon light-activation
45. A proposed structure for transmembrane segment 7 of G protein-coupled receptors incorporating an Asn-Pro/Asp-Pro motif
46. Characterization of heterogenous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty
47. The role of Asp578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor
48. A missense mutation in the second transmembrane domain of the luteinizing hormone receptor causes familial male-limited precocious puberty
49. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male limited precocious puberty
50. Transmembrane regions V an VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop
51. Crystal structure of human chorionic gonadotropin
52. PROCHECK: A program to check the stereochemical quality of protein structures
53. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene
54. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty
55. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male limited precocious puberty
56. Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia
57. A model of the lutropin/choriogonadotropin receptor: Insights into the structural and functional effects of constitutively activating mutations
58. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: Correlation between receptor activity and phenotype
59. Lutropin-choriogonadotropin receptor: An unusual member of the G protein coupled receptor family
60. Model of human chorionic gonadotropin and lutropin receptor interaction that explains signal transduction of the glycoprotein hormones
61. A disulfide bond between conserved extracellular cysteines in the thyrotropin-releasing hormone receptor is critical for binding
62. Topology predictions for helical transmembrane proteins at 86% accuracy
63. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors
64. Constitutively active G protein-coupled receptors: Potential mechanisms of receptor activation
65. Constitutively active mutants of the α1B-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation
66. The activation process of the α1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate
67. Role of the third intracellular loop for the activation of gonadotropin receptors
68. The lutropin/choriogonadotropin receptor . . . 4 years later
69. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F
70. G protein-coupled receptor structure and function: The impact of disease causing mutations
71. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty
72. Tertiary interactions between the fifth and sixth transmembrane segments of rhodopsin
73. Luteinizing hormone receptor mutations and sex differentiation
74. Gonadotropin receptor mutations
75. Activating and inactivating mutations in LH receptors
76. Arrangement of rhodopsin transmembrane α-helices
77. WHAT IF: A molecular modeling and drug design program
78. G-protein-coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition
79. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty
80. Three-dimensional structure of the cytoplasmic face of the G-protein receptor rhodopsin
81. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin releasing hormone receptor